петък, 2 октомври 2020 г.

Weekly Update: New diabetes clinical trial (18 items)


New diabetes clinical trial: Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood

Published on: August 03, 2020 at 07:00PM
Conditions:   Type 2 Diabetes;   Insulin Sensitivity/Resistance;   Inflammatory Response;   Fatty Acids, Omega-3
Intervention:   Dietary Supplement: Omega-3 fatty acids (2.7 g/d, EPA:DHA, 2:1)
Sponsors:   May Faraj, PDt, PhD;   Canadian Institutes of Health Research (CIHR)
Completed
https://clinicaltrials.gov/ct2/show/NCT04496154?term=diabetes&sfpd_d=14 August 03, 2020 at 04:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Enriched Eggs for Retina Health in Type 2 Diabetes

Published on: August 03, 2020 at 07:00PM
Condition:   Diabetic Retinopathy
Interventions:   Other: Docosahexaenoic Acid and Lutein Enriched Eggs;   Other: Regular Eggs
Sponsors:   University of Manitoba;   Egg Farmers of Canada
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04496817?term=diabetes&sfpd_d=14 August 03, 2020 at 04:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Intestinimonas for Prevention of Type 2 Diabetes Mellitus

Published on: August 03, 2020 at 07:00PM
Condition:   PreDiabetes
Interventions:   Dietary Supplement: Intestinimonas-capsules;   Dietary Supplement: Placebo-capsules
Sponsor:   Caelus Pharmaceuticals BV
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04495972?term=diabetes&sfpd_d=14 August 03, 2020 at 04:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Sitagliptin for the Treatment of Type 2 Diabetes

Published on: August 03, 2020 at 07:00PM
Condition:   Type 2 Diabetes
Intervention:   Drug: Sitagliptin 100mg
Sponsor:   Beijing Chao Yang Hospital
Recruiting
https://clinicaltrials.gov/ct2/show/NCT04495881?term=diabetes&sfpd_d=14 August 03, 2020 at 04:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Influence of Diet on Pregnancy With Polyhydramnios

Published on: August 04, 2020 at 07:00PM
Condition:   Polyhydramnios
Intervention:   Other: Diet as recommended for gestational diabetes
Sponsor:   Wolfson Medical Center
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04497532?term=diabetes&sfpd_d=14 August 04, 2020 at 02:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Safety and Efficacy of Empagliflozin for Patients With Diabetes Mellitus and Planned Percutaneous Coronary Interventions

Published on: August 04, 2020 at 07:00PM
Conditions:   Coronary Artery Disease;   Diabetes Mellitus;   Percutaneous Coronary Intervention
Interventions:   Drug: Empagliflozin 10Mg Tab;   Drug: hypoglycemic therapy
Sponsor:   Research Institute for Complex Problems of Cardiovascular Diseases, Russia
Completed
https://clinicaltrials.gov/ct2/show/NCT04497792?term=diabetes&sfpd_d=14 August 04, 2020 at 02:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Survey of Patient and Physician Awareness and Values to the Diagnosis and Treatment of Reduced Kidney Function (Chronic Kidney Disease) in Patients With High Blood Sugar Level (Type 2 Diabetes) (AWARE-CKD in T2D)

Published on: August 04, 2020 at 07:00PM
Condition:   Renal Insufficiency, Chronic
Intervention:   Other: No intervention
Sponsors:   Bayer;   LMC Diabetes & Endocrinology
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04498156?term=diabetes&sfpd_d=14 August 04, 2020 at 02:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Educational Intervention Targeting Statin Therapy and Compliance in Diabetic Patients

Published on: August 05, 2020 at 07:00PM
Condition:   Type II Diabetes
Intervention:   Other: Therapeutic education
Sponsor:   Lille Catholic University
Recruiting
https://clinicaltrials.gov/ct2/show/NCT04499846?term=diabetes&sfpd_d=14 August 05, 2020 at 02:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Wearable Technology and a Virtual Lifestyle Program for Type 2 Diabetics

Published on: August 05, 2020 at 07:00PM
Conditions:   Type 2 Diabetes;   Comorbidities and Coexisting Conditions
Intervention:   Behavioral: Wearable Activity Trackers, Exercise Prescription and Virtual Care
Sponsor:   Western University, Canada
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04498819?term=diabetes&sfpd_d=14 August 05, 2020 at 02:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Pilot Study to Assess the Effects of Hepatic Ultrasound Insonification on Subjects With T2DM

Published on: August 06, 2020 at 07:00PM
Condition:   Type 2 Diabetes
Intervention:   Device: Hepatic Ultrasound Insonification
Sponsors:   General Electric Research;   ProSciento
Recruiting
https://clinicaltrials.gov/ct2/show/NCT04502212?term=diabetes&sfpd_d=14 August 06, 2020 at 02:24PM

via ClinicalTrials.gov


New diabetes clinical trial: BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients

Published on: August 06, 2020 at 07:00PM
Condition:   T2D
Interventions:   Biological: Bone-marrow aspiration, Intra-pancreatic Catheterisation of BM-MNC;   Biological: Intravenous Infusion of UC-MSC
Sponsors:   Indonesia University;   Dr Cipto Mangunkusumo General Hospital
Recruiting
https://clinicaltrials.gov/ct2/show/NCT04501341?term=diabetes&sfpd_d=14 August 06, 2020 at 02:24PM

via ClinicalTrials.gov


New diabetes clinical trial: A Trial to Compare BioChaperone Insulin Lispro Formulations With US Approved Humalog® and With EU Approved Humalog® in Patients With Type 1 Diabetes Mellitus

Published on: August 06, 2020 at 07:00PM
Condition:   Type 1 Diabetes
Interventions:   Drug: Administration of BioChaperone insulin lispro reconstituted with Humalog® (IMP1);   Drug: Administration of Ready-to-use BioChaperone insulin lispro (IMP2);   Drug: Administration of US-approved Humalog® (IMP3);   Drug: Administration of EU-approved Humalog® (IMP4)
Sponsor:   Adocia
Recruiting
https://clinicaltrials.gov/ct2/show/NCT04501107?term=diabetes&sfpd_d=14 August 06, 2020 at 02:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Short-term Impact of COVID-19 Lockdown on Metabolic Control of Type 2 Diabetes

Published on: August 06, 2020 at 07:00PM
Conditions:   Type 2 Diabetes;   Metabolic Control
Intervention:   Other: antidiabetic treatment
Sponsor:   University of Pisa
Completed
https://clinicaltrials.gov/ct2/show/NCT04501991?term=diabetes&sfpd_d=14 August 06, 2020 at 02:24PM

via ClinicalTrials.gov


New diabetes clinical trial: "FEXIS": (Feasibility of an Extended Wear CSII Set in Participants With T1DM)

Published on: August 07, 2020 at 07:00PM
Conditions:   Diabetes Mellitus, Type 1;   Type 1 Diabetes;   Type 1 Diabetes Mellitus;   Diabetes Mellitus, Insulin-Dependent, 1
Intervention:   Device: coil-reinforced soft polymer indwelling cannula
Sponsor:   Capillary Biomedical, Inc.
Recruiting
https://clinicaltrials.gov/ct2/show/NCT04503564?term=diabetes&sfpd_d=14 August 07, 2020 at 02:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Effectiveness of a Multimodal Intervention on Function in Older Frail People With Diabetes in Latinamerican

Published on: August 07, 2020 at 07:00PM
Conditions:   Frailty Syndrome;   Frail Elderly Syndrome;   Diabetes Mellitus, Type 2
Interventions:   Other: Multimodal intervention;   Other: Usual care group
Sponsors:   Consorcio Centro de Investigación Biomédica en Red, M.P.;   Pan American Health Organization;   Catholic University of the Sacred Heart;   Diabetes Frail Ltd;   University of Castilla-La Mancha;   Confederación Española de Organizaciones de Mayores (CEOMA);   Pontificia Universidad Javeriana;   Pontificia Universidad Catolica de Chile;   Instituto de Geriatria, Mexico;   Universidad de San Martín de Porres (USMP);   Universidad de Santiago de Chile (USACH)
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04504968?term=diabetes&sfpd_d=14 August 07, 2020 at 02:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy

Published on: August 07, 2020 at 07:00PM
Condition:   PB-119, GLP-1RA, Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy
Interventions:   Drug: GLP-1 receptor agonist;   Drug: Placebo
Sponsor:   PegBio Co., Ltd.
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04504396?term=diabetes&sfpd_d=14 August 07, 2020 at 02:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Metformin's Effect on Drug Metabolism in Patients With Type 2 Diabetes

Published on: August 07, 2020 at 07:00PM
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Metformin;   Drug: Caffeine;   Drug: Efavirenz;   Drug: Losartan;   Drug: Omeprazol;   Drug: Metoprolol;   Drug: Midazolam
Sponsor:   University of Southern Denmark
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04504045?term=diabetes&sfpd_d=14 August 07, 2020 at 02:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Prediabetes and Type 2 Diabetes Data Collection Study

Published on: August 07, 2020 at 07:00PM
Conditions:   Diabetes Mellitus, Type 2;   Pre-diabetes
Intervention:   Device: G6
Sponsor:   DexCom, Inc.
Recruiting
https://clinicaltrials.gov/ct2/show/NCT04503239?term=diabetes&sfpd_d=14 August 07, 2020 at 02:24PM

via ClinicalTrials.gov


Няма коментари:

Публикуване на коментар